Michael J Li1,2, Erica Su3, Wendy H Garland1,4, Sona Oksuzyan1,4, Sung-Jae Lee1,5, Uyen H Kao1,2, Robert E Weiss1,3, Steven J Shoptaw1,2,5. 1. Center for HIV Identification Prevention and Treatment Services, University of California, Los Angeles, CA. 2. Department of Family Medicine, Center for Behavioral and Addiction Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA. 3. Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, CA. 4. Division of HIV and STD Programs, Los Angeles County Department of Public Health, Los Angeles, CA; and. 5. Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA.
Abstract
BACKGROUND: In March of 2013, the Los Angeles County (LAC) Division of HIV and STD Programs implemented a clinic-based Medical Care Coordination (MCC) Program to increase viral suppression (VS) (<200 c/mL) among people living with HIV (PLWH) at high risk for poor health outcomes. OBJECTIVE: This study aimed to estimate trajectories of VS and to assess whether these trajectories differed by stimulant use, housing instability, and depressive symptom severity as reported by PLWH participating in MCC. METHODS: Data represent 6408 PLWH in LAC receiving services from the MCC Program and were obtained from LAC HIV surveillance data matched to behavioral assessments obtained across 35 Ryan White Program clinics participating in MCC. Piecewise mixed-effects logistic regression with a random intercept estimated probabilities of VS from 12 months before MCC enrollment through 36 months after enrollment, accounting for time by covariate interactions for 3 comorbid conditions: housing instability, stimulant use, and depressive symptoms. RESULTS: The overall probability of VS increased from 0.35 to 0.77 within the first 6 months in the MCC Program, and this probability was maintained up to 36 months after enrollment. Those who reported housing instability, stimulant use, or multiple comorbid conditions did not achieve the same probability of VS by 36 months as those with none of those comorbidities. CONCLUSIONS: Findings suggest that MCC improved the probability of VS for all patient groups regardless of the presence of comorbidities. However, those with comorbid conditions will still require increased support from patient-centered programs to address disparities in VS.
BACKGROUND: In March of 2013, the Los Angeles County (LAC) Division of HIV and STD Programs implemented a clinic-based Medical Care Coordination (MCC) Program to increase viral suppression (VS) (<200 c/mL) among people living with HIV (PLWH) at high risk for poor health outcomes. OBJECTIVE: This study aimed to estimate trajectories of VS and to assess whether these trajectories differed by stimulant use, housing instability, and depressive symptom severity as reported by PLWH participating in MCC. METHODS: Data represent 6408 PLWH in LAC receiving services from the MCC Program and were obtained from LAC HIV surveillance data matched to behavioral assessments obtained across 35 Ryan White Program clinics participating in MCC. Piecewise mixed-effects logistic regression with a random intercept estimated probabilities of VS from 12 months before MCC enrollment through 36 months after enrollment, accounting for time by covariate interactions for 3 comorbid conditions: housing instability, stimulant use, and depressive symptoms. RESULTS: The overall probability of VS increased from 0.35 to 0.77 within the first 6 months in the MCC Program, and this probability was maintained up to 36 months after enrollment. Those who reported housing instability, stimulant use, or multiple comorbid conditions did not achieve the same probability of VS by 36 months as those with none of those comorbidities. CONCLUSIONS: Findings suggest that MCC improved the probability of VS for all patient groups regardless of the presence of comorbidities. However, those with comorbid conditions will still require increased support from patient-centered programs to address disparities in VS.
Authors: M Reuel Friedman; Ron Stall; Anthony J Silvestre; Chongyi Wei; Steve Shoptaw; Amy Herrick; Pamela J Surkan; Linda Teplin; Michael W Plankey Journal: AIDS Date: 2015-06-01 Impact factor: 4.177
Authors: Angela A Aidala; Michael G Wilson; Virginia Shubert; David Gogolishvili; Jason Globerman; Sergio Rueda; Anne K Bozack; Maria Caban; Sean B Rourke Journal: Am J Public Health Date: 2015-11-12 Impact factor: 9.308
Authors: Sara Croxford; Aileen Kitching; Sarika Desai; Meaghan Kall; Michael Edelstein; Andrew Skingsley; Fiona Burns; Andrew Copas; Alison E Brown; Ann K Sullivan; Valerie Delpech Journal: Lancet Public Health Date: 2016-12-15
Authors: Moses J E Flash; Wendy H Garland; Emily B Martey; Bruce R Schackman; Sona Oksuzyan; Justine A Scott; Philip J Jeng; Marisol Rubio; Elena Losina; Kenneth A Freedberg; Sonali P Kulkarni; Emily P Hyle Journal: Open Forum Infect Dis Date: 2019-12-16 Impact factor: 3.835
Authors: Steve Shoptaw; Michael J Li; Marjan Javanbakht; Amy Ragsdale; David Goodman-Meza; Pamina M Gorbach Journal: Drug Alcohol Depend Date: 2022-01-19 Impact factor: 4.492
Authors: Michael J Li; Emily I Richter; Chukwuemeka N Okafor; Mariah M Kalmin; Shareefa Dalvie; Sae Takada; Pamina M Gorbach; Steven J Shoptaw; Steven W Cole Journal: Ann Behav Med Date: 2022-08-30
Authors: Elliott R Weinstein; Audrey Harkness; Gail Ironson; Cho-Hee Shrader; Dustin T Duncan; Steven A Safren Journal: Int J Behav Med Date: 2022-05-02
Authors: Jennifer A Fulcher; Marjan Javanbakht; Chelsea L Shover; Amy Ragsdale; Ron Brookmeyer; Steven Shoptaw; Pamina M Gorbach Journal: Drug Alcohol Depend Date: 2021-02-16 Impact factor: 4.492